CompletedPhase 1

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

MD Clinical

Hallandale, Florida, United States

+20 additional locations

Save this trial

MD ClinicalHallandale, Florida, United States
Munroe Regional Medical CenterOcala, Florida, United States
Renstar Medical ResearchOcala, Florida, United States
Trinity Care SolutionsOcala, Florida, United States
Advanced Imaging of OcalaOcala, Florida, United States
Atlanta Center for Medical ResearchAtlanta, Georgia, United States
Foers Medical Arts PharmacyBethesda, Maryland, United States
CBH Health, LLCRockville, Maryland, United States
Borgess Medical CenterKalamazoo, Michigan, United States
Borgess Research InstituteKalamazoo, Michigan, United States
KNI Southwest Michigan Imaging Center, LLCKalamazoo, Michigan, United States
Millennium Psychiatric Associates, LLCCreve Coeur, Missouri, United States
DePaul Health Center-MRI DepartmentSt Louis, Missouri, United States
Memory Enhancement Center of America, Inc.Eatontown, New Jersey, United States
Central Jersey RadiologyOakhurst, New Jersey, United States
Seoul National University Hospital, Department NeurologySeongnam-si, Gyeonggi-do, South Korea
Inha University Hospital, Department of NeurologyIncheon, South Korea
Samsung Medical Center, Department of NeurologySeoul, South Korea
Korea University Anam Hospital IRBSeoul, South Korea
ASAN Medical CenterSeoul, South Korea
Konkuk University Medical Center, Department of NeurologySeoul, South Korea